Cardiac Valve Involvement in Rheumatoid Arthritis: A Case-Control Study Among Adult Patients in Sulaimaniyah Province
-
Published:2023-06-20
Issue:1
Volume:25
Page:9
-
ISSN:2521-4853
-
Container-title:Journal of Zankoy Sulaimani - Part A
-
language:
-
Short-container-title:JZS
Author:
Hadi Krmanj,Mirza Raouf,Saeedq Dana,Ahmed Farman
Abstract
Background: The frequency of valvular heart disease (VHD) among rheumatoid arthritis (RA) patients varies in the literature ranging between 3-70%. This considerable variability might be attributed to the examined population's varied genetic backgrounds and the different methodologies utilized to identify valvular disease. VHD resulting in severe symptomatic aortic insufficiency is an uncommon RA consequence.
Objectives: This study aimed to look for cardiac valve involvement in RA patients and determine whether it is linked with disease activity and duration.
Methods: Fifty RA patients were recruited consecutively, 5 were males, and 45 were females, aged 27 to 65 years, with a mean of 49.86 ± 9.98. All patients were free from cardiac diseases and underwent entire history, physical examination, laboratory test, and transthoracic echocardiography. The findings were compared to those of age and gender-matched controls, who had no rheumatic and cardiac diseases.
Results: Valvular lesions were found in 18 (36%) RA patients, whereas only 2 (4%) of the controls had valvular lesions (p= 0.000063). The most frequently affected valve was the mitral valve 11(61%). There was no relationship between VHD and the duration of the disease, clinical disease activity index (CDAI) score, body mass index (BMI), and smoking.
Conclusions: This study has confirmed that VHD (specific to the mitral valve) is significantly higher in RA patients compared with the control sample. There was no correlation between VHD and RA's disease duration, clinical, laboratory, or treatment characteristics.
Publisher
Journal of Zankoy Sulaimani - Part A
Reference26 articles.
1. England, B. R., Thiele, G. M., Anderson, D. R., & Mikuls, T. R. (2018). Increased cardiovascular risk in rheumatoid arthritis: Mechanisms and implications. BMJ (Online), 361, k1036. https://doi.org/10.1136/bmj.k1036 2. Firestein, G. S., Budd, R. C., Gabriel, S. E., McInnes, I. B., & O’Dell, J. R. (2020). Firestein & Kelley’s textbook of rheumatology. Elsevier Health Sciences. 3. Adebajo, A., Dunkley, L. and Trakoli, A. (2019) ‘ABC of Rheumatology’, Occupational Medicine, 69(4), pp. 303–303. Available at: https://doi.org/10.1093/OCCMED/KQZ035 4. Andrianakos, A., Trontzas, P., Christoyannis, F., Kaskani, E., Nikolia, Z., Tavaniotou, E., Georgountzos, A., & Krachtis, P. (2006). Prevalence and management of rheumatoid arthritis in the general population of Greece--the ESORDIG study. Rheumatology (Oxford, England), 45(12), 1549–1554. https://doi.org/10.1093/rheumatology/kel140 5. Leblond, A., Allanore, Y., & Avouac, J. (2017). Targeting synovial neoangiogenesis in rheumatoid arthritis. Autoimmunity Reviews, 16(6), 594–601. https://doi.org/10.1016/j.autrev.2017.04.005
|
|